Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2016 (2016), Article ID 8239258, 13 pages
http://dx.doi.org/10.1155/2016/8239258
Review Article

Annexin A1 and the Resolution of Inflammation: Modulation of Neutrophil Recruitment, Apoptosis, and Clearance

1Programa de Pós-Graduação em Ciências Farmacêuticas, Faculdade de Farmácia, Universidade Federal de Minas Gerais, 31270-901 Belo Horizonte, MG, Brazil
2Departamento de Análises Clínicas e Toxicológicas, Faculdade de Farmácia, Universidade Federal de Minas Gerais, 31270-901 Belo Horizonte, MG, Brazil
3Laboratório de Imunofarmacologia, Departamento de Bioquímica e Imunologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, 31270-901 Belo Horizonte, MG, Brazil
4Programa de Pós-Graduação em Biologia Celular, Departamento de Morfologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, 31270-901 Belo Horizonte, MG, Brazil

Received 29 August 2015; Accepted 1 December 2015

Academic Editor: Nicolas Demaurex

Copyright © 2016 Michelle Amantéa Sugimoto et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Medzhitov, “Inflammation 2010: new adventures of an old flame,” Cell, vol. 140, no. 6, pp. 771–776, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. M. T. Silva and M. Correia-Neves, “Neutrophils and macrophages: the main partners of phagocyte cell systems,” Frontiers in Immunology, vol. 3, article 174, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. J. M. Hallett, A. E. Leitch, N. A. Riley, R. Duffin, C. Haslett, and A. G. Rossi, “Novel pharmacological strategies for driving inflammatory cell apoptosis and enhancing the resolution of inflammation,” Trends in Pharmacological Sciences, vol. 29, no. 5, pp. 250–257, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. S. E. Headland and L. V. Norling, “The resolution of inflammation: principles and challenges,” Seminars in Immunology, vol. 27, no. 3, pp. 149–160, 2015. View at Publisher · View at Google Scholar
  5. C. Nathan and A. Ding, “Nonresolving inflammation,” Cell, vol. 140, no. 6, pp. 871–882, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. D. Gilroy and R. De Maeyer, “New insights into the resolution of inflammation,” Seminars in Immunology, vol. 27, no. 3, pp. 161–168, 2015. View at Publisher · View at Google Scholar
  7. C. N. Serhan and J. Savill, “Resolution of inflammation: the beginning programs the end,” Nature Immunology, vol. 6, no. 12, pp. 1191–1197, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. L. P. Sousa, A. L. Alessandri, V. Pinho, and M. M. Teixeira, “Pharmacological strategies to resolve acute inflammation,” Current Opinion in Pharmacology, vol. 13, no. 4, pp. 625–631, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. C. N. Serhan, S. Yacoubian, and R. Yang, “Anti-inflammatory and proresolving lipid mediators,” Annual Review of Pathology: Mechanisms of Disease, vol. 3, pp. 279–312, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. C. N. Serhan, J. Dalli, R. A. Colas, J. W. Winkler, and N. Chiang, “Protectins and maresins: new pro-resolving families of mediators in acute inflammation and resolution bioactive metabolome,” Biochimica et Biophysica Acta, vol. 1851, no. 4, pp. 397–413, 2015. View at Publisher · View at Google Scholar · View at Scopus
  11. J. P. Vago, C. R. Nogueira, L. P. Tavares et al., “Annexin A1 modulates natural and glucocorticoid-induced resolution of inflammation by enhancing neutrophil apoptosis,” Journal of Leukocyte Biology, vol. 92, no. 2, pp. 249–258, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Perretti and J. Dalli, “Exploiting the Annexin A1 pathway for the development of novel anti-inflammatory therapeutics,” British Journal of Pharmacology, vol. 158, no. 4, pp. 936–946, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. P. Raynal and H. B. Pollard, “Annexins: the problem of assessing the biological role for a gene family of multifunctional calcium- and phospholipid-binding proteins,” Biochimica et Biophysica Acta—Biomembranes, vol. 1197, no. 1, pp. 63–93, 1994. View at Publisher · View at Google Scholar · View at Scopus
  14. V. Gerke and S. E. Moss, “Annexins: from structure to function,” Physiological Reviews, vol. 82, no. 2, pp. 331–371, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. V. Gerke, C. E. Creutz, and S. E. Moss, “Annexins: linking Ca2+ signalling to membrane dynamics,” Nature Reviews Molecular Cell Biology, vol. 6, no. 6, pp. 449–461, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. R. J. Flower and G. J. Blackwell, “Anti-inflammatory steroids induce biosynthesis of a phospholipase A2 inhibitor which prevents prostaglandin generation,” Nature, vol. 278, no. 5703, pp. 456–459, 1979. View at Publisher · View at Google Scholar · View at Scopus
  17. G. Cirino and R. J. Flower, “Human recombinant lipocortin 1 inhibits prostacyclin production by human umbilical artery in vitro,” Prostaglandins, vol. 34, no. 1, pp. 59–62, 1987. View at Publisher · View at Google Scholar · View at Scopus
  18. G. Cirino, R. J. Flower, J. L. Browning, L. K. Sinclair, and R. B. Pepinsky, “Recombinant human lipocortin 1 inhibits thromboxane release from guinea-pig isolated perfused lung,” Nature, vol. 328, no. 6127, pp. 270–272, 1987. View at Publisher · View at Google Scholar · View at Scopus
  19. F. D'Acquisto, M. Perretti, and R. J. Flower, “Annexin-A1: a pivotal regulator of the innate and adaptive immune systems,” British Journal of Pharmacology, vol. 155, no. 2, pp. 152–169, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Perretti and F. D'Acquisto, “Annexin A1 and glucocorticoids as effectors of the resolution of inflammation,” Nature Reviews Immunology, vol. 9, no. 1, pp. 62–70, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Rosengarth, V. Gerke, and H. Luecke, “X-ray structure of full-length annexin 1 and implications for membrane aggregation,” Journal of Molecular Biology, vol. 306, no. 3, pp. 489–498, 2001. View at Publisher · View at Google Scholar · View at Scopus
  22. N.-J. Hu, J. Bradshaw, H. Lauter, J. Buckingham, E. Solito, and A. Hofmann, “Membrane-induced folding and structure of membrane-bound annexin A1 N-terminal peptides: implications for annexin-induced membrane aggregation,” Biophysical Journal, vol. 94, no. 5, pp. 1773–1781, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. S. M. Oliani, M. J. Paul-Clark, H. C. Christian, R. J. Flower, and M. Perretti, “Neutrophil interaction with inflamed postcapillary venule endothelium alters annexin 1 expression,” American Journal of Pathology, vol. 158, no. 2, pp. 603–615, 2001. View at Publisher · View at Google Scholar · View at Scopus
  24. U. Rescher, V. Goebeler, A. Wilbers, and V. Gerke, “Proteolytic cleavage of annexin 1 by human leukocyte elastase,” Biochimica et Biophysica Acta—Molecular Cell Research, vol. 1763, no. 11, pp. 1320–1324, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. L. Vong, F. D'Acquisto, M. Pederzoli-Ribeil et al., “Annexin 1 cleavage in activated neutrophils: a pivotal role for proteinase 3,” The Journal of Biological Chemistry, vol. 282, no. 41, pp. 29998–30004, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. J. Dalli, A. P. Consalvo, V. Ray et al., “Proresolving and tissue-protective actions of annexin A1-based cleavage-resistant peptides are mediated by formyl peptide receptor 2/lipoxin A4 receptor,” Journal of Immunology, vol. 190, no. 12, pp. 6478–6487, 2013. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Pederzoli-Ribeil, F. Maione, D. Cooper et al., “Design and characterization of a cleavage-resistant Annexin A1 mutant to control inflammation in the microvasculature,” Blood, vol. 116, no. 20, pp. 4288–4296, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. S. F. Smith, T. D. Tetley, A. Guz, and R. J. Flower, “Detection of lipocortin 1 in human lung lavage fluid: lipocortin degradation as a possible proteolytic mechanism in the control of inflammatory mediators and inflammation,” Environmental Health Perspectives, vol. 85, pp. 135–144, 1990. View at Publisher · View at Google Scholar · View at Scopus
  29. F. H. C. Tsao, K. C. Meyer, X. Chen, N. S. Rosenthal, and J. Hu, “Degradation of annexin I in bronchoalveolar lavage fluid from patients with cystic fibrosis,” American Journal of Respiratory Cell and Molecular Biology, vol. 18, no. 1, pp. 120–128, 1998. View at Publisher · View at Google Scholar · View at Scopus
  30. F. H. C. Tsao, Z. Xiang, A. Abbasi, and K. C. Meyer, “Neutrophil necrosis and annexin 1 degradation associated with airway inflammation in lung transplant recipients with cystic fibrosis,” BMC Pulmonary Medicine, vol. 12, article 44, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. M. Perretti, S. K. Wheller, R. J. Flower, S. Wahid, and C. Pitzalis, “Modulation of cellular annexin I in human leukocytes infiltrating DTH skin reactions,” Journal of Leukocyte Biology, vol. 65, no. 5, pp. 583–589, 1999. View at Google Scholar · View at Scopus
  32. S. L. Williams, I. R. Milne, C. J. Bagley et al., “A proinflammatory role for proteolytically cleaved annexin A1 in neutrophil transendothelial migration,” Journal of Immunology, vol. 185, no. 5, pp. 3057–3063, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. R. Hannon, J. D. Croxtall, S. J. Getting et al., “Aberrant inflammation and resistance to glucocorticoids in annexin 1−/− mouse,” The FASEB Journal, vol. 17, no. 2, pp. 253–255, 2003. View at Google Scholar · View at Scopus
  34. Y. H. Yang, E. F. Morand, S. J. Getting et al., “Modulation of inflammation and response to dexamethasone by Annexin 1 in antigen-induced arthritis,” Arthritis & Rheumatism, vol. 50, no. 3, pp. 976–984, 2004. View at Publisher · View at Google Scholar · View at Scopus
  35. A. S. Damazo, S. Yona, R. J. Flower, M. Perretti, and S. M. Oliani, “Spatial and temporal profiles for anti-inflammatory gene expression in leukocytes during a resolving model of peritonitis,” The Journal of Immunology, vol. 176, no. 7, pp. 4410–4418, 2006. View at Publisher · View at Google Scholar · View at Scopus
  36. F. N. E. Gavins, E. L. Hughes, N. A. P. S. Buss, P. M. Holloway, S. J. Getting, and J. C. Buckingham, “Leukocyte recruitment in the brain in sepsis: involvement of the annexin 1-FPR2/ALX anti-inflammatory system,” FASEB Journal, vol. 26, no. 12, pp. 4977–4989, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. A. P. Girol, K. K. O. Mimura, C. C. Drewes et al., “Anti-inflammatory mechanisms of the annexin A1 protein and its mimetic peptide Ac2-26 in models of ocular inflammation in vivo and in vitro,” Journal of Immunology, vol. 190, no. 11, pp. 5689–5701, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. W. Kao, R. Gu, Y. Jia et al., “A formyl peptide receptor agonist suppresses inflammation and bone damage in arthritis,” British Journal of Pharmacology, vol. 171, no. 17, pp. 4087–4096, 2014. View at Publisher · View at Google Scholar · View at Scopus
  39. A. D. Gimenes, T. R. Andrade, C. B. Mello et al., “Beneficial effect of annexin A1 in a model of experimental allergic conjunctivitis,” Experimental Eye Research, vol. 134, pp. 24–32, 2015. View at Google Scholar
  40. M. Drechsler, R. de Jong, J. Rossaint et al., “Annexin A1 counteracts chemokine-induced arterial myeloid cell recruitment,” Circulation Research, vol. 116, no. 5, pp. 827–835, 2015. View at Publisher · View at Google Scholar
  41. D. G. Souza, C. T. Fagundes, F. A. Amaral et al., “The required role of endogenously produced lipoxin A4 and annexin-1 for the production of IL-10 and inflammatory hyporesponsiveness in mice,” Journal of Immunology, vol. 179, no. 12, pp. 8533–8543, 2007. View at Publisher · View at Google Scholar · View at Scopus
  42. G. Leoni, P. Neumann, N. Kamaly et al., “Annexin A1-containing extracellular vesicles and polymeric nanoparticles promote epithelial wound repair,” Journal of Clinical Investigation, vol. 125, no. 3, pp. 1215–1227, 2015. View at Publisher · View at Google Scholar
  43. R. D. Ye, F. Boulay, M. W. Ji et al., “International union of basic and clinical pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family,” Pharmacological Reviews, vol. 61, no. 2, pp. 119–161, 2009. View at Publisher · View at Google Scholar · View at Scopus
  44. Y. Li, L. Cai, H. Wang et al., “Pleiotropic regulation of macrophage polarization and tumorigenesis by formyl peptide receptor-2,” Oncogene, vol. 30, no. 36, pp. 3887–3899, 2011. View at Publisher · View at Google Scholar · View at Scopus
  45. S. Bena, V. Brancaleone, J. M. Wang, M. Perretti, and R. J. Flower, “Annexin A1 interaction with the FPR2/ALX receptor: identification of distinct domains and downstream associated signaling,” The Journal of Biological Chemistry, vol. 287, no. 29, pp. 24690–24697, 2012. View at Publisher · View at Google Scholar · View at Scopus
  46. N. Chiang, I. M. Fierro, K. Gronert, and C. N. Serhan, “Activation of lipoxin A4 receptors by aspirin-triggered lipoxins and select peptides evokes ligand-specific responses in inflammation,” The Journal of Experimental Medicine, vol. 191, no. 7, pp. 1197–1207, 2000. View at Publisher · View at Google Scholar · View at Scopus
  47. S. N. Cooray, T. Gobbetti, T. Montero-Melendez et al., “Ligand-specific conformational change of the G-protein-coupled receptor ALX/FPR2 determines proresolving functional responses,” Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 45, pp. 18232–18237, 2013. View at Publisher · View at Google Scholar · View at Scopus
  48. A. Walther, K. Riehemann, and V. Gerke, “A novel ligand of the formyl peptide receptor: annexin I regulates neutrophil extravasation by interacting with FPR,” Molecular Cell, vol. 5, no. 5, pp. 831–840, 2000. View at Publisher · View at Google Scholar · View at Scopus
  49. J. Dalli, T. Montero-Melendez, S. McArthur, and M. Perretti, “Annexin A1 N-terminal derived peptide Ac2-26 exerts chemokinetic effects on human neutrophils,” Frontiers in Pharmacology, vol. 3, article 28, 2012. View at Publisher · View at Google Scholar · View at Scopus
  50. V. Brancaleone, J. Dalli, S. Bena, R. J. Flower, G. Cirino, and M. Perretti, “Evidence for an anti-inflammatory loop centered on polymorphonuclear leukocyte formyl peptide receptor 2/lipoxin A4 receptor and operative in the inflamed microvasculature,” The Journal of Immunology, vol. 186, no. 8, pp. 4905–4914, 2011. View at Publisher · View at Google Scholar · View at Scopus
  51. B. D. Levy, C. B. Clish, B. Schmidt, K. Gronert, and C. N. Serhan, “Lipid mediator class switching during acute inflammation: signals in resolution,” Nature Immunology, vol. 2, no. 7, pp. 612–619, 2001. View at Publisher · View at Google Scholar · View at Scopus
  52. O. Haworth, M. Cernadas, R. Yang, C. N. Serhan, and B. D. Levy, “Resolvin E1 regulates interleukin 23, interferon-γ and lipoxin A4 to promote the resolution of allergic airway inflammation,” Nature Immunology, vol. 9, no. 8, pp. 873–879, 2008. View at Publisher · View at Google Scholar · View at Scopus
  53. C. Nathan, “Neutrophils and immunity: challenges and opportunities,” Nature Reviews Immunology, vol. 6, no. 3, pp. 173–182, 2006. View at Publisher · View at Google Scholar · View at Scopus
  54. R. P. G. Hayhoe, A. M. Kamal, E. Solito, R. J. Flower, D. Cooper, and M. Perretti, “Annexin 1 and its bioactive peptide inhibit neutrophil-endothelium interactions under flow: indication of distinct receptor involvement,” Blood, vol. 107, no. 5, pp. 2123–2130, 2006. View at Publisher · View at Google Scholar · View at Scopus
  55. D. H. Kusters, M. L. Chatrou, B. A. Willems et al., “Pharmacological treatment with annexin A1 reduces atherosclerotic plaque burden in LDLR-/- mice on western type diet,” PLoS ONE, vol. 10, no. 6, Article ID e0130484, 2015. View at Publisher · View at Google Scholar
  56. L. H. K. Lim, E. Solito, F. Russo-Marie, R. J. Flower, and M. Perretti, “Promoting detachment of neutrophils adherent to murine postcapillary venules to control inflammation: effect of lipocortin 1,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 24, pp. 14535–14539, 1998. View at Publisher · View at Google Scholar · View at Scopus
  57. E. Solito, A. Kamal, F. Russo-Marie, J. C. Buckingham, S. Marullo, and M. Perretti, “A novel calcium-dependent proapoptotic effect of annexin 1 on human neutrophils,” The FASEB Journal, vol. 17, no. 11, pp. 1544–1546, 2003. View at Google Scholar · View at Scopus
  58. H. J. Strausbaugh and S. D. Rosen, “A potential role for annexin 1 as a physiologic mediator of glucocorticoid-induced L-selectin shedding from myeloid cells,” The Journal of Immunology, vol. 166, no. 10, pp. 6294–6300, 2001. View at Publisher · View at Google Scholar · View at Scopus
  59. M. Perretti and R. J. Flower, “Modulation of IL-1-induced neutrophil migration by dexamethasone and lipocortin 1,” The Journal of Immunology, vol. 150, no. 3, pp. 992–999, 1993. View at Google Scholar · View at Scopus
  60. C. Zouki, S. Ouellet, and J. G. Filep, “The anti-inflammatory peptides, antiflammins, regulate the expression of adhesion molecules on human leukocytes and prevent neutrophil adhesion to endothelial cells,” The FASEB Journal, vol. 14, no. 3, pp. 572–580, 2000. View at Google Scholar · View at Scopus
  61. J. J. Moreno, “Antiflammin-2 prevents HL-60 adhesion to endothelial cells and prostanoid production induced by lipopolysaccharides,” Journal of Pharmacology and Experimental Therapeutics, vol. 296, no. 3, pp. 884–889, 2001. View at Google Scholar · View at Scopus
  62. R. A. P. Teixeira, K. K. O. Mimura, L. P. Araujo, K. V. Greco, and S. M. Oliani, “The essential role of annexin A1 mimetic peptide in the skin allograft survival,” Journal of Tissue Engineering and Regenerative Medicine, 2013. View at Publisher · View at Google Scholar · View at Scopus
  63. K. E. Blume, S. Soeroes, H. Keppeler et al., “Cleavage of annexin A1 by ADAM10 during secondary necrosis generates a monocytic ‘find-me’ signal,” Journal of Immunology, vol. 188, no. 1, pp. 135–145, 2012. View at Publisher · View at Google Scholar · View at Scopus
  64. S. McArthur, T. Gobbetti, D. H. Kusters, C. P. Reutelingsperger, R. J. Flower, and M. Perretti, “Definition of a novel pathway centered on lysophosphatidic acid to recruit monocytes during the resolution phase of tissue inflammation,” The Journal of Immunology, vol. 195, no. 3, pp. 1139–1151, 2015. View at Publisher · View at Google Scholar
  65. M. Scannell, M. B. Flanagan, A. DeStefani et al., “Annexin-1 and peptide derivatives are released by apoptotic cells and stimulate phagocytosis of apoptotic neutrophils by macrophages,” The Journal of Immunology, vol. 178, no. 7, pp. 4595–4605, 2007. View at Publisher · View at Google Scholar · View at Scopus
  66. K. E. Blume, S. Soeroes, M. Waibel et al., “Cell surface externalization of annexin A1 as a failsafe mechanism preventing inflammatory responses during secondary necrosis,” The Journal of Immunology, vol. 183, no. 12, pp. 8138–8147, 2009. View at Publisher · View at Google Scholar · View at Scopus
  67. P. Maderna, S. Yona, M. Perretti, and C. Godson, “Modulation of phagocytosis of apoptotic neutrophils by supernatant from dexamethasone-treated macrophages and annexin-derived peptide Ac2–26,” The Journal of Immunology, vol. 174, no. 6, pp. 3727–3733, 2005. View at Publisher · View at Google Scholar
  68. I. Locatelli, S. Sutti, A. Jindal et al., “Endogenous annexin A1 is a novel protective determinant in nonalcoholic steatohepatitis in mice,” Hepatology, vol. 60, no. 2, pp. 531–544, 2014. View at Publisher · View at Google Scholar · View at Scopus
  69. S. McArthur, E. Cristante, M. Paterno et al., “Annexin A1: a central player in the anti-inflammatory and neuroprotective role of microglia,” Journal of Immunology, vol. 185, no. 10, pp. 6317–6328, 2010. View at Publisher · View at Google Scholar · View at Scopus
  70. D. Pupjalis, J. Goetsch, D. J. Kottas, V. Gerke, and U. Rescher, “Annexin A1 released from apoptotic cells acts through formyl peptide receptors to dampen inflammatory monocyte activation via JAK/STAT/SOCS signalling,” EMBO Molecular Medicine, vol. 3, no. 2, pp. 102–114, 2011. View at Publisher · View at Google Scholar · View at Scopus
  71. P. Subramanian, I. Mitroulis, G. Hajishengallis, and T. Chavakis, “Regulation of tissue infiltration by neutrophils: role of integrin α3β1 and other factors,” Current Opinion in Hematology, vol. 23, no. 1, pp. 36–43, 2016. View at Publisher · View at Google Scholar
  72. M. Perretti, J. D. Croxtall, S. K. Wheller, N. J. Goulding, R. Hannon, and R. J. Flower, “Mobilizing lipocortin 1 in adherent human leukocytes downregulates their transmigration,” Nature Medicine, vol. 2, no. 11, pp. 1259–1262, 1996. View at Publisher · View at Google Scholar · View at Scopus
  73. C. D. Gil, M. La, M. Perretti, and S. M. Oliani, “Interaction of human neutrophils with endothelial cells regulates the expression of endogenous proteins annexin 1, galectin-1 and galectin-3,” Cell Biology International, vol. 30, no. 4, pp. 338–344, 2006. View at Publisher · View at Google Scholar · View at Scopus
  74. T. S. Gastardelo, A. S. Damazo, J. Dalli, R. J. Flower, M. Perretti, and S. M. Oliani, “Functional and ultrastructural analysis of annexin A1 and its receptor in extravasating neutrophils during acute inflammation,” The American Journal of Pathology, vol. 174, no. 1, pp. 177–183, 2009. View at Publisher · View at Google Scholar · View at Scopus
  75. J. Dalli, L. V. Norling, D. Renshaw, D. Cooper, K.-Y. Leung, and M. Perretti, “Annexin 1 mediates the rapid anti-inflammatory effects of neutrophil-derived microparticles,” Blood, vol. 112, no. 6, pp. 2512–2519, 2008. View at Publisher · View at Google Scholar · View at Scopus
  76. A. Montresor, L. Toffali, G. Constantin, and C. Laudanna, “Chemokines and the signaling modules regulating integrin affinity,” Frontiers in Immunology, vol. 3, article 127, 2012. View at Publisher · View at Google Scholar · View at Scopus
  77. J. L. Bos, K. de Bruyn, J. Enserink et al., “The role of Rap1 in integrin-mediated cell adhesion,” Biochemical Society Transactions, vol. 31, no. 1, pp. 83–86, 2003. View at Publisher · View at Google Scholar · View at Scopus
  78. B. Stuqui, M. de Paula-Silva, C. P. Carlos et al., “Ac2-26 mimetic peptide of annexin A1 inhibits local and systemic inflammatory processes induced by Bothrops moojeni venom and the Lys-49 phospholipase A2 in a rat model,” PLoS ONE, vol. 10, no. 7, Article ID e0130803, 2015. View at Publisher · View at Google Scholar
  79. B. C. Guido, M. Zanatelli, W. Tavares-De-Lima, S. M. Oliani, and A. S. Damazo, “Annexin-A1 peptide down-regulates the leukocyte recruitment and up-regulates interleukin-10 release into lung after intestinal ischemia-reperfusion in mice,” Journal of Inflammation, vol. 10, no. 1, article 10, 2013. View at Publisher · View at Google Scholar · View at Scopus
  80. L. Miele, E. Cordella-Miele, A. Facchiano, and A. B. Mukherjee, “Novel anti-inflammatory peptides from the region of highest similarity between uteroglobin and lipocortin I,” Nature, vol. 335, no. 6192, pp. 726–730, 1988. View at Publisher · View at Google Scholar · View at Scopus
  81. A. M. Kamal, R. P. G. Hayhoe, A. Paramasivam et al., “Antiflammin-2 activates the human formyl-peptide receptor like 1,” TheScientificWorldJOURNAL, vol. 6, pp. 1375–1384, 2006. View at Publisher · View at Google Scholar
  82. N. Chiang, C. N. Serhan, S.-E. Dahlén et al., “The lipoxin receptor ALX: potent ligand-specific and stereoselective actions in vivo,” Pharmacological Reviews, vol. 58, no. 3, pp. 463–487, 2006. View at Publisher · View at Google Scholar · View at Scopus
  83. C. Summers, S. M. Rankin, A. M. Condliffe, N. Singh, A. M. Peters, and E. R. Chilvers, “Neutrophil kinetics in health and disease,” Trends in Immunology, vol. 31, no. 8, pp. 318–324, 2010. View at Publisher · View at Google Scholar · View at Scopus
  84. T. Tak, K. Tesselaar, J. Pillay, J. A. M. Borghans, and L. Koenderman, “What's your age again? Determination of human neutrophil half-lives revisited,” Journal of Leukocyte Biology, vol. 94, no. 4, pp. 595–601, 2013. View at Publisher · View at Google Scholar · View at Scopus
  85. J. G. Filep and D. El Kebir, “Neutrophil apoptosis: a target for enhancing the resolution of inflammation,” Journal of Cellular Biochemistry, vol. 108, no. 5, pp. 1039–1046, 2009. View at Publisher · View at Google Scholar · View at Scopus
  86. D. El Kebir, L. József, and J. G. Filep, “Opposing regulation of neutrophil apoptosis through the formyl peptide receptor-like 1/lipoxin A4 receptor: implications for resolution of inflammation,” Journal of Leukocyte Biology, vol. 84, no. 3, pp. 600–606, 2008. View at Publisher · View at Google Scholar · View at Scopus
  87. Y. Tabe, L. Jin, R. Contractor et al., “Novel role of HDAC inhibitors in AML1/ETO AML cells: activation of apoptosis and phagocytosis through induction of annexin A1,” Cell Death and Differentiation, vol. 14, no. 8, pp. 1443–1456, 2007. View at Publisher · View at Google Scholar · View at Scopus
  88. T. Montero-Melendez, J. Dalli, and M. Perretti, “Gene expression signature-based approach identifies a pro-resolving mechanism of action for histone deacetylase inhibitors,” Cell Death and Differentiation, vol. 20, no. 4, pp. 567–575, 2013. View at Publisher · View at Google Scholar · View at Scopus
  89. A. G. Rossi, D. A. Sawatzky, A. Walker et al., “Cyclin-dependent kinase inhibitors enhance the resolution of inflammation by promoting inflammatory cell apoptosis,” Nature Medicine, vol. 12, no. 9, pp. 1056–1064, 2006. View at Publisher · View at Google Scholar · View at Scopus
  90. E. E. McGrath, H. M. Marriott, A. Lawrie et al., “TNF-related apoptosis-inducing ligand (TRAIL) regulates inflammatory neutrophil apoptosis and enhances resolution of inflammation,” Journal of Leukocyte Biology, vol. 90, no. 5, pp. 855–865, 2011. View at Publisher · View at Google Scholar · View at Scopus
  91. C. D. Lucas, D. A. Dorward, M. A. Tait et al., “Downregulation of Mcl-1 has anti-inflammatory pro-resolution effects and enhances bacterial clearance from the lung,” Mucosal Immunology, vol. 7, no. 4, pp. 857–868, 2014. View at Publisher · View at Google Scholar · View at Scopus
  92. I. K. H. Poon, C. D. Lucas, A. G. Rossi, and K. S. Ravichandran, “Apoptotic cell clearance: basic biology and therapeutic potential,” Nature Reviews Immunology, vol. 14, no. 3, pp. 166–180, 2014. View at Publisher · View at Google Scholar · View at Scopus
  93. P. Maderna and C. Godson, “Phagocytosis of apoptotic cells and the resolution of inflammation,” Biochimica et Biophysica Acta (BBA)—Molecular Basis of Disease, vol. 1639, no. 3, pp. 141–151, 2003. View at Publisher · View at Google Scholar · View at Scopus
  94. O. Soehnlein, L. Lindbom, and C. Weber, “Mechanisms underlying neutrophil-mediated monocyte recruitment,” Blood, vol. 114, no. 21, pp. 4613–4623, 2009. View at Publisher · View at Google Scholar · View at Scopus
  95. H. L. Wright, R. J. Moots, R. C. Bucknall, and S. W. Edwards, “Neutrophil function in inflammation and inflammatory diseases,” Rheumatology, vol. 49, no. 9, pp. 1618–1631, 2010. View at Publisher · View at Google Scholar · View at Scopus
  96. K. S. Ravichandran, “Beginnings of a good apoptotic meal: the find-me and eat-me signaling pathways,” Immunity, vol. 35, no. 4, pp. 445–455, 2011. View at Publisher · View at Google Scholar · View at Scopus
  97. S. Arur, U. E. Uche, K. Rezaul et al., “Annexin I is an endogenous ligand that mediates apoptotic cell engulfment,” Developmental Cell, vol. 4, no. 4, pp. 587–598, 2003. View at Publisher · View at Google Scholar · View at Scopus
  98. P. Maderna, D. C. Cottell, T. Toivonen et al., “FPR2/ALX receptor expression and internalization are critical for lipoxin A4 and annexin-derived peptide-stimulated phagocytosis,” The FASEB Journal, vol. 24, no. 11, pp. 4240–4249, 2010. View at Publisher · View at Google Scholar · View at Scopus
  99. S. Yona, S. E. M. Heinsbroek, L. Peiser, S. Gordon, M. Perretti, and R. J. Flower, “Impaired phagocytic mechanism in annexin 1 null macrophages,” British Journal of Pharmacology, vol. 148, no. 4, pp. 469–477, 2006. View at Publisher · View at Google Scholar · View at Scopus
  100. J. Dalli, C. P. Jones, D. M. Cavalcanti, S. H. Farsky, M. Perretti, and S. M. Rankin, “Annexin A1 regulates neutrophil clearance by macrophages in the mouse bone marrow,” The FASEB Journal, vol. 26, no. 1, pp. 387–396, 2012. View at Publisher · View at Google Scholar · View at Scopus
  101. R. E. Voll, M. Herrmann, E. A. Roth, C. Stach, J. R. Kalden, and I. Girkontaite, “Immunosuppressive effects of apoptotic cells,” Nature, vol. 390, no. 6658, pp. 350–351, 1997. View at Publisher · View at Google Scholar · View at Scopus
  102. V. A. Fadok, D. L. Bratton, A. Konowal, P. W. Freed, J. Y. Westcott, and P. M. Henson, “Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-β, PGE2, and PAF,” The Journal of Clinical Investigation, vol. 101, no. 4, pp. 890–898, 1998. View at Publisher · View at Google Scholar · View at Scopus
  103. M.-L. N. Huynh, V. A. Fadok, and P. M. Henson, “Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF-β1 secretion and the resolution of inflammation,” Journal of Clinical Investigation, vol. 109, no. 1, pp. 41–50, 2002. View at Publisher · View at Google Scholar · View at Scopus
  104. A. S. Damazo, S. Yona, F. D'Acquisto, R. J. Flower, S. M. Oliani, and M. Perretti, “Critical protective role for annexin 1 gene expression in the endotoxemic murine microcirculation,” American Journal of Pathology, vol. 166, no. 6, pp. 1607–1617, 2005. View at Publisher · View at Google Scholar · View at Scopus
  105. Y. H. Yang, D. Aeberli, A. Dacumos, J. R. Xue, and E. F. Morand, “Annexin-1 regulates macrophage IL-6 and TNF via glucocorticoid-induced leucine zipper,” Journal of Immunology, vol. 183, no. 2, pp. 1435–1445, 2009. View at Publisher · View at Google Scholar · View at Scopus
  106. P. Del Gaudio, F. De Cicco, R. P. Aquino et al., “Evaluation of in situ injectable hydrogels as controlled release device for ANXA1 derived peptide in wound healing,” Carbohydrate Polymers, vol. 115, pp. 629–633, 2015. View at Publisher · View at Google Scholar · View at Scopus
  107. N. Kamaly, G. Fredman, M. Subramanian et al., “Development and in vivo efficacy of targeted polymeric inflammation-resolving nanoparticles,” Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 16, pp. 6506–6511, 2013. View at Publisher · View at Google Scholar · View at Scopus
  108. G. Fredman, N. Kamaly, S. Spolitu et al., “Targeted nanoparticles containing the proresolving peptide Ac2-26 protect against advanced atherosclerosis in hypercholesterolemic mice,” Science Translational Medicine, vol. 7, no. 275, Article ID 275ra20, 2015. View at Publisher · View at Google Scholar · View at Scopus